Source-grounded facts extracted from UTAH MEDICAL PRODUCTS INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
UTAH MEDICAL PRODUCTS INC shareholders approved Advisory vote on executive compensation at the 2026-05-01 meeting.
“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,354,919 Against 38,451 Abstentions 7,603 Broker Non-Votes 372,329”
UTAH MEDICAL PRODUCTS INC shareholders approved Ratification of Haynie & Co. as independent public accounting firm at the 2026-05-01 meeting.
“Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2026: For 2,753,278 Against 16,273 Abstentions 3,751”
UTAH MEDICAL PRODUCTS INC shareholders approved Election of Directors at the 2026-05-01 meeting.
“Elected Ernst G. Hoyer as a director of the Company: For 1,330,333 Withheld 1,070,640 Broker Non-Votes 372,329 Elected James H. Beeson as a director of the Company: For 1,708,941 Withheld 692,032 Broker Non-Votes 372,329”
Carrie Leigh was appointed as Director at UTAH MEDICAL PRODUCTS INC.
“On November 1, 2024, the Board of Directors of Utah Medical Products, Inc. (UTMD) voted to increase the size of the Board of Directors from five to six members and to appoint Carrie Leigh to fill the vacancy created by the increase in the number of directors.”
UTAH MEDICAL PRODUCTS INC shareholders approved Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion at the 2024-05-03 meeting.
“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,662,106 Against 72,899 Abstentions 6,064 Broker Non Votes 324,644”
UTAH MEDICAL PRODUCTS INC shareholders approved Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024 at the 2024-05-03 meeting.
“Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024: For 3,012,801 Against 49,443 Abstentions 3,469”
UTAH MEDICAL PRODUCTS INC shareholders approved Elected Kevin L. Cornwell as a director of the Company at the 2024-05-03 meeting.
“Elected Kevin L. Cornwell as a director of the Company: For 1,436,389 Withheld 1,304,680 Broker Non Votes 324,644 Elected Paul O. Richins as a director of the Company: For 907,483 Withheld 1,833,586 Broker Non Votes 324,644”
UTAH MEDICAL PRODUCTS INC shareholders approved Frequency of future advisory votes on executive compensation at the 2023-05-05 meeting.
“Indicated a preference, the frequency of future advisory votes on the Company's executive compensation program: Every year: 2,412,492 Every two years: 17,765 Every three years: 167,728 Abstain: 199,248 Broker Non Votes: 371,084”
UTAH MEDICAL PRODUCTS INC shareholders approved Advisory vote on executive compensation at the 2023-05-05 meeting.
“Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,719,953 Against 72,499 Abstentions 4,781 Broker Non Votes 371,084”
UTAH MEDICAL PRODUCTS INC shareholders approved Ratification of Haynie & Co. as independent public accounting firm at the 2023-05-05 meeting.
“Ratified the selection of Haynie & Co. as the Company's independent public accounting firm for the year ended December 31, 2023: For 3,138,164 Against 27,552 Abstentions 2,601”
UTAH MEDICAL PRODUCTS INC shareholders rejected 2023 Employees’ and Directors’ Incentive Plan at the 2023-05-05 meeting.
“Did not approve the 2023 Employees’ and Directors’ Incentive Plan: For 1,168,480 Against 1,590,668 Abstentions 38,085”
UTAH MEDICAL PRODUCTS INC shareholders approved Election of Directors at the 2023-05-05 meeting.
“Elected Ernst G. Hoyer as a director of the Company: For 871,160 Withheld 1,926,073 Broker Non Votes 371,084 Elected James H. Beeson as a director of the Company: For 1,277,218 Withheld 1,520,015 Broker Non Votes 371,084”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.